Ken Griffin Citadel Advisors
AUM
$115B
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
This Quarter Return
+0.05%
1 Year Return
+4.22%
3 Year Return
+14.25%
5 Year Return
+23%
10 Year Return
+57.51%
AUM
$102B
AUM Growth
+$102B
(-2.1%)
Cap. Flow
+$910M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
12.82%
Holding
7,202
New
1,005
Increased
2,418
Reduced
2,283
Closed
1,231
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$1.35B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$1.1B |
| 3 |
Apple
AAPL
|
$556M |
| 4 |
Thermo Fisher Scientific
TMO
|
$488M |
| 5 |
Coca-Cola
KO
|
$464M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.46B |
| 2 |
Microsoft
MSFT
|
$777M |
| 3 |
McDonald's
MCD
|
$585M |
| 4 |
JPMorgan Chase
JPM
|
$466M |
| 5 |
Meta Platforms (Facebook)
META
|
$455M |
Sector Composition
| 1 | Technology | 16.54% |
| 2 | Healthcare | 16.17% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 10.91% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.05B | 0.62% | 5,596,869 +2,025,899 | +57% | +$1.1B |
|
|
2
Invesco QQQ Trust
QQQ
$369B
| $1.58B | 0.32% | 3,304,542 +2,822,010 | +585% | +$1.35B |
|
3
Amazon
AMZN
$2.44T
| $1.49B | 0.3% | 7,692,857 +1,114,948 | +17% | +$215M |
|
|
4
Apple
AAPL
$3.45T
| $1.15B | 0.23% | 5,472,500 +2,641,580 | +93% | +$556M |
|
|
HES
5
DELISTED
Hess
HES
| $1.08B | 0.22% | 7,345,372 -1,992,991 | -21% | -$294M |
|
|
6
Coca-Cola
KO
$296B
| $1.02B | 0.21% | 16,099,915 +7,282,828 | +83% | +$464M |
|
7
Merck
MRK
$208B
| $1.02B | 0.21% | 8,242,067 +666,847 | +9% | +$82.6M |
|
8
Boston Scientific
BSX
$156B
| $963M | 0.19% | 12,499,867 +3,725,802 | +42% | +$287M |
|
9
Bank of America
BAC
$376B
| $890M | 0.18% | 22,379,085 -5,816,711 | -21% | -$231M |
|
10
Broadcom
AVGO
$1.39T
| $777M | 0.16% | 483,747 +188,074 | +64% | +$302M |
|
11
Intuitive Surgical
ISRG
$168B
| $633M | 0.13% | 1,423,271 -42,747 | -3% | -$19M |
|
12
Walt Disney
DIS
$212B
| $598M | 0.12% | 6,026,558 +4,662,226 | +342% | +$463M |
|
13
Pfizer
PFE
$141B
| $571M | 0.12% | 20,395,633 +7,886,096 | +63% | +$221M |
|
|
14
Microsoft
MSFT
$3.77T
| $556M | 0.11% | 1,243,093 -1,739,036 | -58% | -$777M |
|
|
15
Thermo Fisher Scientific
TMO
$185B
| $543M | 0.11% | 982,694 +882,024 | +876% | +$488M |
|
16
AT&T
T
$209B
| $519M | 0.11% | 27,137,342 +7,360,132 | +37% | +$141M |
|
17
Humana
HUM
$36.2B
| $484M | 0.1% | 1,294,083 +219,922 | +20% | +$82.2M |
|
18
S&P Global
SPGI
$167B
| $460M | 0.09% | 1,031,056 -486,590 | -32% | -$217M |
|
19
Bristol-Myers Squibb
BMY
$95.5B
| $456M | 0.09% | 10,971,677 +10,660,102 | +3,421% | +$443M |
|
20
Eli Lilly
LLY
$658B
| $453M | 0.09% | 500,835 +23,722 | +5% | +$21.5M |
|
21
Equinix
EQIX
$77.2B
| $427M | 0.09% | 564,122 +493,938 | +704% | +$374M |
|
22
Icon
ICLR
$13.8B
| $426M | 0.09% | 1,360,207 +474,000 | +53% | +$149M |
|
23
Target
TGT
$43.5B
| $417M | 0.08% | 2,814,215 +1,577,190 | +127% | +$233M |
|
24
Adobe
ADBE
$150B
| $406M | 0.08% | 730,328 +148,684 | +26% | +$82.6M |
|
25
UnitedHealth
UNH
$274B
| $390M | 0.08% | 765,077 +368,088 | +93% | +$187M |
|